<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-01-20 10:24:44Pharmaceutical sciences Yellow Card Scheme Adverse effect Patient safety Adverse drug reaction Medicines and Healthcare products Regulatory Agency Suspected Adverse Reaction Surveillance Scheme Pharmacovigilance Postmarketing surveillance Medicine Health Pharmacology |
Add to Reading List |
Adverse drug reactions.indd | COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume IDocID: 1qH6O - View Document |
 | IMDRF Presentation - WHO updateDocID: 1q40h - View Document |
 | IMDRF Presentation - Update on WHO workDocID: 1oBkV - View Document |
 | Microsoft Word - Volume IX ENdocDocID: 1g2y9 - View Document |
 | Kyrgyzstan Assessment of Pharmaceutical Data Disclosure Disclosure Status of Pharmaceutical Sector Data Part of Component 1 of the MeTA Baseline Assessments Kyrgyz RepublicDocID: 1fUrF - View Document |